Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart - PubMed (original) (raw)
Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart
A Virkamäki et al. Diabetes. 1999 May.
Abstract
Glucosamine infusion induces insulin resistance in vivo, but the effect of glucosamine on intracellular metabolites of the hexosamine pathway, especially glucosamine-6-phosphate (GlcN6P) is unknown. Because of the structural similarity of glucose-6-phosphate (G-6-P) and GlcN6P, we hypothesized that accumulation of this metabolite might alter the activities of enzymes such as glycogen synthase and hexokinase. We infused glucosamine (30 micromol x kg(-1) x min(-1)) to induce insulin resistance in rats during a euglycemic-hyperinsulinemic clamp. Glucosamine induced whole-body insulin resistance, which was apparent after 90 min and continued progressively for 360 min. Despite inducing severe whole-body insulin resistance and decrease in glycogen synthase fractional activity in rectus abdominis muscle (69+/-3 vs. 83+/-1%, P<0.01) and heart (7+/-1 vs. 32+/-4%, P<0.001), glucosamine did not change the glycogen content in rectus and even increased it in the heart (209+/-13 vs. 117+/-9 mmol/kg dry wt, P<0.001). Glucosamine increased tissue concentrations of UDP-GlcNAc 4.4- and 4.6-fold in rectus abdominis and heart, respectively. However, GlcN6P concentrations increased 500- and 700-fold in glucosamine-infused animals in rectus abdominis (590+/-80 vs. 1.2+/-0.1 micromol/kg wet wt, P<0.001) and heart (7,703+/-993 vs. 11.2+/-2.3 micromol/kg wet wt, P<0.001). To assess the possible significance of GlcN6P accumulation, we measured the effect of GlcN6P on glycogen synthase and hexokinase activity in vitro. At the GlcN6P concentrations measured in rectus abdominis and heart in vivo, glycogen synthase was activated by 21 and 542%, while similar concentrations inhibited hexokinase activity by 5 and 46%, respectively. This study demonstrates that infusion of glucosamine during a euglycemic-hyperinsulinemic clamp results in marked accumulation of intracellular GlcN6P. The GlcN6P concentrations in the heart and rectus abdominis muscle reach levels sufficient to cause allosteric activation of glycogen synthase and inhibition of hexokinase.
Similar articles
- Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal.
Hawkins M, Barzilai N, Chen W, Angelov I, Hu M, Cohen P, Rossetti L. Hawkins M, et al. Diabetes. 1996 Dec;45(12):1734-43. doi: 10.2337/diab.45.12.1734. Diabetes. 1996. PMID: 8922359 - Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues.
Virkamäki A, Daniels MC, Hämäläinen S, Utriainen T, McClain D, Yki-Järvinen H. Virkamäki A, et al. Endocrinology. 1997 Jun;138(6):2501-7. doi: 10.1210/endo.138.6.5172. Endocrinology. 1997. PMID: 9165041 - Role of the glucosamine pathway in fat-induced insulin resistance.
Hawkins M, Barzilai N, Liu R, Hu M, Chen W, Rossetti L. Hawkins M, et al. J Clin Invest. 1997 May 1;99(9):2173-82. doi: 10.1172/JCI119390. J Clin Invest. 1997. PMID: 9151789 Free PMC article. - Mechanisms of insulin resistance in non-oxidative glucose metabolism: the role of glycogen synthase.
Beck-Nielsen H. Beck-Nielsen H. J Basic Clin Physiol Pharmacol. 1998;9(2-4):255-79. doi: 10.1515/JBCPP.1998.9.2-4.255. J Basic Clin Physiol Pharmacol. 1998. PMID: 10212838 Review.
Cited by
- Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities.
Henrotin Y, Chevalier X, Herrero-Beaumont G, McAlindon T, Mobasheri A, Pavelka K, Schön C, Weinans H, Biesalski H; Participants at the Hohenheim Consensus Conference in August 29th 2011. Henrotin Y, et al. BMC Res Notes. 2013 Mar 26;6:115. doi: 10.1186/1756-0500-6-115. BMC Res Notes. 2013. PMID: 23531101 Free PMC article. - O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.
Lima VV, Rigsby CS, Hardy DM, Webb RC, Tostes RC. Lima VV, et al. J Am Soc Hypertens. 2009 Nov-Dec;3(6):374-87. doi: 10.1016/j.jash.2009.09.004. J Am Soc Hypertens. 2009. PMID: 20409980 Free PMC article. - Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG. Buse MG. Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E1-E8. doi: 10.1152/ajpendo.00329.2005. Am J Physiol Endocrinol Metab. 2006. PMID: 16339923 Free PMC article. Review. - Glucosamine-linked near-infrared fluorescent probes for imaging of solid tumor xenografts.
Korotcov AV, Ye Y, Chen Y, Zhang F, Huang S, Lin S, Sridhar R, Achilefu S, Wang PC. Korotcov AV, et al. Mol Imaging Biol. 2012 Aug;14(4):443-51. doi: 10.1007/s11307-011-0520-4. Mol Imaging Biol. 2012. PMID: 21971932 Free PMC article. - O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.
Lima VV, Giachini FR, Hardy DM, Webb RC, Tostes RC. Lima VV, et al. Am J Physiol Regul Integr Comp Physiol. 2011 Feb;300(2):R236-50. doi: 10.1152/ajpregu.00230.2010. Epub 2010 Nov 10. Am J Physiol Regul Integr Comp Physiol. 2011. PMID: 21068200 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous